Molnupiravir

ATC J05AB18 · 5 markets · 8 records

Molnupiravir 5 markets · 8 records Forms
Filters

AU 3 records · 1 shown of 1 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Lagevrio 200mg capsules ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

JP 2 records · 2 shown of 2 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

  • 200 mgcapsuleラゲブリオカプセル200mg also in AU·GB·CN
  • 400 mgtabletラゲブリオ錠400mg

GB 1 records · 1 shown of 1 Source NHSBSA dm+d · Data as of 2026-10-19

CN 1 records · 1 shown of 1 Source 国家医保局 医保药品分类与代码数据库 · Data as of 2025-04-04

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength · includes records with unknown status (not proof of sale)

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Lagevrio 200mg capsules ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

Side-by-side table

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.